PHYSICAL AND PHARMACOLOGICAL RESTRAINT OF NURSING-HOME PATIENTS WITH DEMENTIA - IMPACT OF SPECIALIZED UNITS

被引:83
作者
SLOANE, PD
MATHEW, LJ
SCARBOROUGH, M
DESAI, JR
KOCH, GG
TANGEN, C
机构
[1] UNIV N CAROLINA, SCH PUBL HLTH, DEPT EPIDEMIOL, CHAPEL HILL, NC 27514 USA
[2] UNIV N CAROLINA, SCH PUBL HLTH, DEPT BIOSTAT, CHAPEL HILL, NC 27514 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 265卷 / 10期
关键词
D O I
10.1001/jama.265.10.1278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This case-control study of 31 specialized dementia units and 32 traditional units in five states investigated use of physical and pharmacologic restraints among 625 patients with the diagnosis of dementia. Physical restraints were observed in use on 18.1% of dementia unit patients and on 51.6% of comparison unit patients who were out of bed during the day (adjusted odds ratio, 0.283; 95% confidence interval, 0.129 to 0.619). Pharmacologic restraints were routinely given to 45.3% of dementia unit patients and 43.4% of comparison unit patients (adjusted odds ratio, 0.950; 95% confidence interval, 0.611 to 1.477). We used multivariate logistic regression to identify residence in a nonspecialized nursing home unit, nonambulatory status, transfer dependency, mental status impairment, hip fracture history, and a high nursing staff-to-patient ratio, which we found to be independent predictors of physical restraint use. Physically abusive behavior, severe mental status impairment, and frequent family visitation were found to be significant predictors of pharmacologic restraint use, while advanced patient age, large nursing home size, and patient nonambulatory status were protective against such use. These results support the conclusion that physical and pharmacologic restraints constitute separate treatment modalities with different risk factors for use, and indicate that specialized dementia units are successful in reducing the use of physical but not pharmacologic restraints.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 40 条
[1]  
Ackermann J O, 1985, J Long Term Care Adm, V13, P90
[2]  
APPELBAUM PS, 1984, AM J PSYCHIAT, V141, P202
[3]  
BASEN MM, 1977, PUBLIC HEALTH REP, V92, P43
[4]   PRESCRIBING OF PSYCHOTROPICS IN ELDERLY NURSING-HOME PATIENTS [J].
BEARDSLEY, RS ;
LARSON, DB ;
BURNS, BJ ;
THOMPSON, JW ;
KAMEROW, DB .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (04) :327-330
[5]   PSYCHOACTIVE MEDICATION USE IN INTERMEDIATE-CARE FACILITY RESIDENTS [J].
BEERS, M ;
AVORN, J ;
SOUMERAI, SB ;
EVERITT, DE ;
SHERMAN, DS ;
SALEM, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (20) :3016-3020
[6]   PSYCHOTROPIC-DRUG PRACTICE IN NURSING-HOMES [J].
BUCK, JA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (05) :409-418
[7]  
Calkins M P, 1989, Provider, V15, P7
[8]   AGITATED BEHAVIORS IN THE ELDERLY .2. PRELIMINARY-RESULTS IN THE COGNITIVELY DETERIORATED [J].
COHENMANSFIELD, J .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1986, 34 (10) :722-727
[9]   USE OF MECHANICAL AND CHEMICAL RESTRAINTS IN NURSING-HOMES [J].
COVERT, AB ;
RODRIGUES, T ;
SOLOMON, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1977, 25 (02) :85-89
[10]  
DOANE KW, 1989, CONSULTANT PHARM, V4, P367